Oxaliplatin-based chemotherapy for the treatment of a metastatic carcinoid tumor

被引：0
|
作者：
Eric D. Tetzlaff
Jaffer A. Ajani
机构：
[1] The University of Texas M.D. Anderson Cancer Center,Department of Gastrointestinal Oncology and Digestive Systems
来源：
International Journal of Gastrointestinal Cancer | 2005年 / 36卷 / 1期
关键词：
Carcinoid; chromogranin A; interferon alpha; octreotide; oxaliplatin;
D O I：
10.1385/IJGC:36:1:055
中图分类号：
学科分类号：
摘要：
Carcinoid tumors are rare and often resistant to chemotherapy agents. Although a slow-growing tumor, patients can have significant morbidity associated with carcinoid syndrome and patients will often die as a result of tumor progression. We report the first case of a patient with a metastatic carcinoid tumor to respond to an oxaliplatin-based regimen. Further studies are needed to validate this observation.
引用
收藏
页码：55 / 58
页数：3
相关论文
共 50 条
  • [1] Oxaliplatin-Based Chemotherapy for the Treatment of a Metastatic Carcinoid Tumor
    Tetzlaff, Eric D.
    Ajani, Jaffer A.
    JOURNAL OF GASTROINTESTINAL CANCER, 2005, 36 (01) : 55 - 58
  • [2] Bevacizumab and oxaliplatin-based chemotherapy in metastatic colorectal cancer
    Beatty, Gregory L.
    Giantonio, Bruce J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (05) : 683 - 688
  • [3] Oxaliplatin-based chemotherapy in the treatment of elderly patients with metastatic colorectal cancer (CRC)
    Berretta, Massimiliano
    Zanet, Ernesto
    Nasti, Guglielmo
    Lleshi, Arben
    Frustaci, Sergio
    Fiorica, Francesco
    Bearz, Alessandra
    Talamini, Renato
    Lestuzzi, Chiara
    Lazzarini, Renzo
    Fisichella, Rossella
    Cannizzaro, Renato
    Iaffaioli, Rosario Vincenzo
    Berretta, Salvatore
    Tirelli, Umberto
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2012, 55 (02) : 271 - 275
  • [4] Cetuximab plus oxaliplatin-based chemotherapy in the treatment of colorectal cancer
    Moosmann, Nicolas
    Heinemann, Volker
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (03) : 319 - 329
  • [5] Oxaliplatin-Based Chemotherapy for Colon Cancer
    Bonetti, Andrea
    Furini, Lara
    PLATINUM AND OTHER HEAVY METAL COMPOUNDS IN CANCER CHEMOTHERAPY: MOLECULAR MECHANISMS AND CLINICAL APPLICATIONS, 2009, : 271 - 284
  • [6] Features of peripheral neuropathy during oxaliplatin-based chemotherapy for metastatic colon cancer
    Argyriou, A.
    Polychronopoulos, P.
    Iconomou, G.
    Koutras, A.
    Gourzis, P.
    Assimakopoulos, K.
    Kalofonos, H.
    Chroni, E.
    JOURNAL OF NEUROLOGY, 2007, 254 : 111 - 111
  • [7] Fatal Thrombocytopenia after Oxaliplatin-based Chemotherapy
    Shao, Yu-Yun
    Hong, Ruey-Long
    ANTICANCER RESEARCH, 2008, 28 (5B) : 3115 - 3117
  • [8] Treatment of advanced and/or metastatic colorectal cancer with bevacizumab in combination with oxaliplatin-based chemotherapy (Folfox7 regimen)
    Oukkal, M.
    Djilat, K.
    Hadjam, R. M.
    Mahgoun, M. T.
    Bentabak, K.
    Graba, A.
    Smail, N.
    Kaci, N. Ait
    Ahmed, R. Baba
    Bouzid, K.
    BULLETIN DU CANCER, 2010, 97 (04) : 469 - 474
  • [9] Oxaliplatin-based chemotherapy in the management of colorectal cancer
    Capdevila, Jaume
    Elez, Elena
    Peralta, Sergio
    Macarulla, Teresa
    Javier Ramos, Francisco
    Tabernero, Josep
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (08) : 1223 - 1236
  • [10] Incidence and characteristics of peripheral neuropathy during oxaliplatin-based chemotherapy for metastatic colon cancer
    Argyriou, Andreas A.
    Polychronopoulos, Panagiotis
    Iconomou, Gregoris
    Koutras, Angelos
    Makatsoris, Thomas
    Gerolymos, Miltiadis K.
    Gourzis, Philippos
    Assimakopoulos, Konstantinos
    Kalofonos, Haralabos P.
    Chroni, Elisabeth
    ACTA ONCOLOGICA, 2007, 46 (08) : 1131 - 1137
12345